Successful management of factor IX inhibitor-associated nephrotic syndrome in a hemophilia B patient

Pediatric Nephrology

Volumn 28, Issue 5, 2013, Pages 823-826

  Verghese, Priya ^a   Darrow, Stephen ^a   Kurth, Margaret H ^b   Reed, Robyn C ^c   Kim, Youngki ^a   Kearney, Susan ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b Children's Hospitals   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Factor IX; Hemophilia B; Nephrotic syndrome; Segmental membranous nephropathy

Indexed keywords

ALBUMIN; BLOOD CLOTTING FACTOR 9 CONCENTRATE; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3; CREATININE; DEXAMETHASONE; ENALAPRIL; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RECOMBINANT BLOOD CLOTTING FACTOR 9; RITUXIMAB;

ANAPHYLAXIS; ARTICLE; BLEEDING; CASE REPORT; CHILD; CHILL; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DRUG INDUCED HEADACHE; ECHOGRAPHY; FAMILY HISTORY; FEVER; HEMOPHILIA B; HISTOPATHOLOGY; HUMAN; IMMUNOFLUORESCENCE; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; MALE; MEMBRANOUS GLOMERULONEPHRITIS; MOUTH PAIN; NEPHROTIC SYNDROME; PALLOR; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; REMISSION;

ANTIBODIES; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; BIOPSY; CHILD, PRESCHOOL; COAGULANTS; FACTOR IX; GLOMERULONEPHRITIS, MEMBRANOUS; HEMOPHILIA B; HUMANS; IMMUNE TOLERANCE; IMMUNOSUPPRESSIVE AGENTS; MALE; MYCOPHENOLIC ACID; NEPHROTIC SYNDROME; PROTEINURIA; TIME FACTORS; TREATMENT OUTCOME;

EID: 84880573604     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-012-2397-0     Document Type: Article

References (15)

1. DiMichele D (2007) Inhibitor development in haemophilia B: an orphan disease in need of attention. Br J Haematol 138:305-315
2. Dharnidharka VR, Takemoto C, Ewenstein BM, Rosen S, Harris HW (1998) Membranous glomerulonephritis and nephrosis post factor IX infusions in hemophilia B. Pediatr Nephrol 12:654-657
3. Klarmann D, Martinez Saguer I, Funk MB, Knoefler R, von Hentig N, Heller C, Kreuz W (2008) Immune tolerance induction with mycophenolate-mofetil in two children with haemophilia B and inhibitor. Haemophilia 14:44-49
4. Jadhav M, Warrier I (2000) Anaphylaxis in patients with hemophilia. Semin Thromb Hemost 26:205-208
5. Ewenstein BM, Takemoto C, Warrier I, Lusher J, Saidi P, Eisele J, Ettinger LJ, DiMichele D (1997) Nephrotic syndrome as a complication of immune tolerance in hemophilia B. Blood 89:1115-1116
6. Gaffney EF, Alexander RW, Donnelly WH (1982) Segmental membranous glomerulonephritis. Arch Pathol Lab Med 106:409-412
7. Segawa Y, Hisano S, Matsushita M, Fujita T, Hirose S, Takeshita M, Iwasaki H (2010) IgG subclasses and complement pathway in segmental and global membranous nephropathy. Pediatr Nephrol 25:1091-1099
8. Beck LH Jr, Fervenza FC, Beck DM, Bonegio RG, Malik FA, Erickson SB, Cosio FG, Cattran DC, Salant DJ (2011) Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy. J Am Soc Nephrol 22:1543-1550
9. Remuzzi G, Chiurchiu C, Abbate M, Brusegan V, Bontempelli M, Ruggenenti P (2002) Rituximab for idiopathic membranous nephropathy. Lancet 360:923-924
10. Barnes C, Davis A, Furmedge J, Egan B, Donnan L, Monagle P (2010) Induction of immune tolerance using rituximab in a child with severe haemophilia B with inhibitors and anaphylaxis to factor IX. Haemophilia 16:840-841
11. Terasaki PI (2003) Humoral theory of transplantation. Am J Transplant 3:665-673
12. Mizutani K, Terasaki P, Rosen A, Esquenazi V, Miller J, Shih RN, Pei R, Ozawa M, Lee J (2005) Serial ten-year follow-up of HLA and MICA antibody production prior to kidney graft failure. Am J Transplant 5:2265-2272
13. Fornoni A, Sageshima J, Wei C, Merscher-Gomez S, Aguillon-Prada R, Jauregui AN, Li J, Mattiazzi A, Ciancio G, Chen L, Zilleruelo G, Abitbol C, Chandar J, Seeherunvong W, Ricordi C, Ikehata M, Rastaldi MP, Reiser J, Burke GW 3rd (2011) Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis. Sci Trans Med 3:85ra46
14. Hall CL, Fothergill NJ, Blackwell MM, Harrison PR, MacKenzie JC, MacIver AG (1987) The natural course of gold nephropathy: long-term study of 21 patients. Br Med J 295:745-748
15. Fervenza FC, Abraham RS, Erickson SB, Irazabal MV, Eirin A, Specks U, Nachman PH, Bergstralh EJ, Leung N, Cosio FG, Hogan MC, Dillon JJ, Hickson LJ, Li X, Cattran DC (2010) Rituximab therapy in idiopathic membranous nephropathy: a 2-year study. Clin J Am Soc Nephrol 5:2188-2198